Kristen Marino

Kristen Marino is a Senior Principal Scientist at Cellarity, leading molecular modeling efforts for Myelofibrosis and NASH programs since November 2022. Previously, Kristen served as Principal Scientist in Computational Chemistry where her work on the sickle-cell disease program resulted in two published patents and significant advancements in compound prioritization and analysis. With a robust background in computational chemistry and protein modeling across companies such as LifeMine Therapeutics and Silicon Therapeutics, Kristen has extensive experience in molecular dynamics simulations, druggability analysis, and the integration of biophysics data. Kristen's academic credentials include a PhD in Chemical Engineering from Princeton University and a Bachelor's Degree from Lehigh University.